CervoMed Inc.
CRVO
$2.73
-$0.20-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -34.22% | -60.88% | -65.53% | -114.15% | -348.36% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 788.46% | 912.66% | 277.96% | 36.27% | 103.80% |
| Change in Net Operating Assets | 267.05% | 463.03% | 725.94% | -80.71% | -305.26% |
| Cash from Operations | -20.00% | -45.11% | -41.86% | -126.21% | -205.51% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 36.02% | 187.74% | 163.14% | 158.02% | 142.03% |
| Cash from Investing | 36.02% | 187.74% | 163.14% | 158.02% | 142.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 312.47% | -90.08% | -90.11% | -90.11% | -90.28% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 313.67% | -90.08% | -90.11% | -90.09% | -92.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 937.49% | -161.95% | -163.32% | 163.17% | -118.04% |